|
ES2525585T3
(es)
|
2006-05-05 |
2014-12-26 |
The Regents Of The University Of Michigan |
Intermedios para la preparación de miméticos de SMAC bivalentes
|
|
BRPI0711591A2
(pt)
|
2006-05-16 |
2011-11-16 |
Aegera Therapeutics, Inc. |
composto de ligação de domìnio bir da iap
|
|
WO2008014229A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
WO2008014240A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
PE20110217A1
(es)
|
2006-08-02 |
2011-04-01 |
Novartis Ag |
DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
|
|
WO2008128171A2
(en)
*
|
2007-04-13 |
2008-10-23 |
The Regents Of The University Of Michigan |
Diazo bicyclic smac mimetics and the uses thereof
|
|
EP2296650B1
(en)
|
2008-05-16 |
2020-05-06 |
Novartis AG |
Immunomodulation by iap inhibitors
|
|
US20100317593A1
(en)
|
2009-06-12 |
2010-12-16 |
Astrazeneca Ab |
2,3-dihydro-1h-indene compounds
|
|
ES2643233T3
(es)
|
2009-10-23 |
2017-11-21 |
The Regents Of The University Of Michigan |
Miméticos de SMAC bicíclicos diazo bivalentes y los usos de los mismos
|
|
EP2493879B1
(en)
|
2009-10-28 |
2014-05-14 |
Joyant Pharmaceuticals, Inc. |
Dimeric smac mimetics
|
|
CA2780130A1
(en)
|
2009-11-05 |
2011-05-12 |
The Uab Research Foundation |
Treating basal-like genotype cancers
|
|
JP2014528409A
(ja)
|
2011-09-30 |
2014-10-27 |
テトラロジック ファーマシューティカルズ コーポレーション |
増殖性疾患(がん)の治療において使用するためのSMAC模倣体(ビリナパント(birinapant))
|
|
US8859541B2
(en)
|
2012-02-27 |
2014-10-14 |
Boehringer Ingelheim International Gmbh |
6-alkynylpyridines
|
|
AU2013306087B2
(en)
|
2012-08-23 |
2017-08-10 |
The Regents Of The University Of Michigan |
Bivalent inhibitors of IAP proteins and therapeutic methods using the same
|
|
CA2896577C
(en)
|
2012-11-30 |
2024-01-23 |
Sanford-Burnham Medical Research Institute |
Inhibitor of apoptosis protein (iap) antagonists
|
|
WO2014121178A1
(en)
|
2013-02-04 |
2014-08-07 |
Tetralogic Pharmaceuticals Corp. |
Smac mimetic method of treatment
|
|
US9278978B2
(en)
|
2013-08-23 |
2016-03-08 |
Boehringer Ingelheim International Gmbh |
6-Alkynyl Pyridine
|
|
US9249151B2
(en)
|
2013-08-23 |
2016-02-02 |
Boehringer Ingelheim International Gmbh |
Bis-amido pyridines
|
|
CN115368356B
(zh)
|
2013-12-20 |
2025-05-09 |
阿斯特克斯治疗有限公司 |
双环杂环化合物及其治疗用途
|
|
AR101479A1
(es)
|
2014-08-11 |
2016-12-21 |
Boehringer Ingelheim Int |
Derivados de 6-alquinil-piridina
|
|
KR20170066546A
(ko)
|
2014-10-03 |
2017-06-14 |
노파르티스 아게 |
조합 요법
|
|
WO2016079527A1
(en)
|
2014-11-19 |
2016-05-26 |
Tetralogic Birinapant Uk Ltd |
Combination therapy
|
|
AU2015360095B2
(en)
*
|
2014-12-09 |
2020-02-27 |
Advenchen Laboratories Nanjing Ltd |
Quinoline derivative against non-small cell lung cancer
|
|
CA2916970A1
(en)
|
2016-01-08 |
2017-07-08 |
Pharmascience Inc. |
A smac mimetic compound for use in the treatment of proliferative diseases
|
|
EP3419643A4
(en)
|
2016-02-24 |
2020-04-01 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
SMC COMBINATION THERAPY FOR TREATING CANCER
|
|
CN110475567A
(zh)
|
2017-03-31 |
2019-11-19 |
勃林格殷格翰国际有限公司 |
抗癌组合疗法
|
|
WO2019122941A1
(en)
*
|
2017-12-21 |
2019-06-27 |
Debiopharm International Sa |
Combination anti cancer therapy with an iap antagonist and an anti pd-1 molecule
|